Ishares Biotechnology Etf Price Patterns
| IBB Etf | USD 172.43 0.00 0.00% |
Momentum 51
Impartial
Oversold | Overbought |
Using IShares Biotechnology hype-based prediction, you can estimate the value of iShares Biotechnology ETF from the perspective of IShares Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards IShares Biotechnology using IShares Biotechnology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards IShares using crowd psychology based on the activity and movement of IShares Biotechnology's stock price.
IShares Biotechnology Implied Volatility | 0.21 |
IShares Biotechnology's implied volatility exposes the market's sentiment of iShares Biotechnology ETF stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if IShares Biotechnology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that IShares Biotechnology stock will not fluctuate a lot when IShares Biotechnology's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in IShares Biotechnology to buy its etf at a price that has no basis in reality. In that case, they are not buying IShares because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell etfs at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
IShares Biotechnology after-hype prediction price | USD 172.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as etf price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current IShares contract
Based on the Rule 16, the options market is currently suggesting that iShares Biotechnology ETF will have an average daily up or down price movement of about 0.0131% per day over the life of the 2026-04-17 option contract. With IShares Biotechnology trading at USD 172.43, that is roughly USD 0.0226 . If you think that the market is fully incorporating IShares Biotechnology's daily price movement you should consider acquiring iShares Biotechnology ETF options at the current volatility level of 0.21%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out IShares Biotechnology Basic Forecasting Models to cross-verify your projections. IShares Biotechnology After-Hype Price Density Analysis
As far as predicting the price of IShares Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in IShares Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Etf prices, such as prices of IShares Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
IShares Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting IShares Biotechnology's etf value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on IShares Biotechnology's historical news coverage. IShares Biotechnology's after-hype downside and upside margins for the prediction period are 171.50 and 173.96, respectively. We have considered IShares Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
IShares Biotechnology is very steady at this time. Analysis and calculation of next after-hype price of iShares Biotechnology ETF is based on 3 months time horizon.
IShares Biotechnology Etf Price Outlook Analysis
Have you ever been surprised when a price of a ETF such as IShares Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading IShares Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Etf price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with IShares Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 1.23 | 0.30 | 0.02 | 9 Events / Month | 5 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
172.43 | 172.73 | 0.17 |
|
IShares Biotechnology Hype Timeline
On the 31st of January iShares Biotechnology ETF is traded for 172.43. The entity has historical hype elasticity of 0.3, and average elasticity to hype of competition of 0.02. IShares is forecasted to increase in value after the next headline, with the price projected to jump to 172.73 or above. The average volatility of media hype impact on the company the price is about 66.13%. The price jump on the next news is projected to be 0.17%, whereas the daily expected return is currently at 0.16%. The volatility of related hype on IShares Biotechnology is about 1171.43%, with the expected price after the next announcement by competition of 172.45. Considering the 90-day investment horizon the next forecasted press release will be in about 9 days. Check out IShares Biotechnology Basic Forecasting Models to cross-verify your projections.IShares Biotechnology Related Hype Analysis
Having access to credible news sources related to IShares Biotechnology's direct competition is more important than ever and may enhance your ability to predict IShares Biotechnology's future price movements. Getting to know how IShares Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how IShares Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IJT | iShares SP Small Cap | 0.18 | 14 per month | 0.93 | 0.01 | 1.66 | (1.53) | 4.91 | |
| IJS | iShares SP Small Cap | 2.26 | 7 per month | 0.88 | 0.05 | 2.32 | (1.82) | 5.07 | |
| EWT | iShares MSCI Taiwan | 0.19 | 6 per month | 1.20 | 0.08 | 1.85 | (2.17) | 4.93 | |
| IJJ | iShares SP Mid Cap | (1.13) | 7 per month | 0.73 | 0.03 | 1.92 | (1.27) | 4.42 | |
| IDV | iShares International Select | (0.20) | 5 per month | 0.00 | 0.24 | 1.37 | (0.74) | 2.47 | |
| IXN | iShares Global Tech | 0.58 | 7 per month | 1.58 | (0.02) | 1.96 | (2.76) | 5.78 | |
| IOO | iShares Global 100 | (0.20) | 6 per month | 0.78 | 0.03 | 1.19 | (1.54) | 4.51 | |
| URTH | iShares MSCI World | 0.30 | 8 per month | 0.74 | 0.01 | 1.09 | (1.23) | 3.32 | |
| DLN | WisdomTree LargeCap Dividend | 0.43 | 1 per month | 0.43 | 0.01 | 0.91 | (0.80) | 2.55 | |
| VOX | Vanguard Communication Services | (1.36) | 3 per month | 0.75 | 0.05 | 1.90 | (1.35) | 4.23 |
IShares Biotechnology Additional Predictive Modules
Most predictive techniques to examine IShares price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for IShares using various technical indicators. When you analyze IShares charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About IShares Biotechnology Predictive Indicators
The successful prediction of IShares Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as iShares Biotechnology ETF, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of IShares Biotechnology based on analysis of IShares Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to IShares Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to IShares Biotechnology's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Biotechnology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Biotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Biotechnology Etf:Check out IShares Biotechnology Basic Forecasting Models to cross-verify your projections. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
iShares Biotechnology ETF's market price often diverges from its book value, the accounting figure shown on IShares's balance sheet. Smart investors calculate IShares Biotechnology's intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since IShares Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IShares Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.